Cartesian Therapeutics's total assets for Q3 2024 were $455.32M, an increase of 30.94% from the previous quarter. RNAC total liabilities were $454.56M for the fiscal quarter, a 1.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.